Insider trade

Thomas David Iii Hull, CEO at Kewaunee Scientific Corp, sold ~$1.1K of Kewaunee Scientific Corp shares.

~$1.1K
Approx. value · 29 sh @ $38.00
36K
Holds after · shares reported
Traded
Dec 30, 2025
Filed
Jan 2, 2026

What stands out in this filing

  • The sale was 0.1% of the shares this insider held before it; the filing reports 35,806 shares afterwards.
  • 29 shares at an average of $38.00 each, as reported on the form.
  • No footnote on the form refers to a pre-arranged trading plan (Rule 10b5-1).

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Dec 4, 2025Company filing · Form 8-K · Material agreement, Agreement endedSigned an important agreement, and ended an important agreement (and 2 more items)
  2. Dec 10, 2025Company filing · Form 8-K · ResultsReported its results
  3. Dec 17, 2025InsiderCEO sold ~$39K of KEQU shares in the open market
  4. Dec 22, 2025InsiderCEO sold ~$39K of KEQU shares in the open market
  5. Dec 29, 2025InsiderCEO sold ~$34K of KEQU shares in the open market
  6. Dec 30, 2025 · this disclosureInsiderCEO sold ~$1.1K of KEQU shares in the open market

What came next

  1. Dec 31, 2025InsiderCEO sold ~$24K of KEQU shares in the open market
  2. Jan 6, 2026InsiderCFO sold ~$75K of KEQU shares in the open market
  3. Jan 7, 2026InsiderCEO sold ~$82K of KEQU shares in the open market
  4. Mar 11, 2026Company filing · Form 8-K · ResultsReported its results
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Kewaunee Scientific Corp

OQRO holds no insider, Congress, fund or contract record for Kewaunee Scientific Corp dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its KEQU page.

Other recent filings by Thomas David Iii Hull, President, CEO

The full history of Thomas David Iii Hull, President, CEO is on the profile page.

How this filing works

Explore the data

Common questions

Which Kewaunee Scientific Corp (KEQU) insider traded, and how much?

Thomas David Iii Hull, CEO at Kewaunee Scientific Corp, sold ~$1.1K of Kewaunee Scientific Corp shares. 29 shares at $38.00.

When did it happen, and when was it made public?

Traded: Dec 30, 2025. Filed: Jan 2, 2026. That is 3 days between the two dates.

What stands out in this filing?

The sale was 0.1% of the shares this insider held before it; the filing reports 35,806 shares afterwards. 29 shares at an average of $38.00 each, as reported on the form. No footnote on the form refers to a pre-arranged trading plan (Rule 10b5-1).

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

Does this mean KEQU stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Kewaunee Scientific Corp

Everything OQRO holds on this company is on its KEQU page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data